| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10016040 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10012545 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10011001 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10012546 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10007207 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10026202 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10034297 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10020768 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10020855 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10047896 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CACNB2 |
|---|---|
| DrugBank ID | DB01023 |
| Drug Name | Felodipine |
| Target ID | BE0002354 |
| UniProt ID | Q08289 |
| Regulation Type | inhibitor |
| PubMed IDs | 11752352; 10525060; 17475903 |
| Citations | Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Furukawa T, Yamakawa T, Midera T, Sagawa T, Mori Y, Nukada T: Selectivities of dihydropyridine derivatives in blocking Ca(2+) channel subtypes expressed in Xenopus oocytes. J Pharmacol Exp Ther. 1999 Nov;291(2):464-73.@@Zahradnikova A, Minarovic I, Zahradnik I: Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists. J Pharmacol Exp Ther. 2007 Aug;322(2):638-45. Epub 2007 May 2. |
| Groups | Approved; Investigational |
| Direct Classification | Dihydropyridinecarboxylic acids and derivatives |
| SMILES | CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC |
| Pathways | Felodipine Metabolism Pathway; Felodipine Action Pathway |
| PharmGKB | PA449591 |
| ChEMBL | CHEMBL1480 |
